Article Sidebar
Views pdf: 71
EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENT USING THE ESOMEPRAZOLE, BISMUTH, METRONIDAZOLE, TETRACYCLINE REGIMEN IN GASTRITIS AND IRRITABLE BOWEL SYNDROME
Main Article Content
Abstract
Background: Infection with Helicobacter pylori (H. pylori) is associated with upper gastrointestinal diseases such as gastritis, peptic ulcers, and increases the risk of developing Irritable Bowel Syndrome (IBS). The eradication treatment for H. pylori may help improve symptoms of IBS. Objective: To evaluate the effectiveness of H. pylori eradication treatment using the Esomeprazole, Bismuth, Metronidazole, Tetracycline (EBMT) regimen in patients with gastritis and Irritable Bowel Syndrome (IBS). Materials and Methods: The study was conducted on 77 patients diagnosed with gastritis and Irritable Bowel Syndrome. They were treated for H. pylori eradication using the 4-drug EBMT regimen for 14 days. Results: The success rate of H. pylori eradication using the EBMT regimen over 14 days was 96.1%. Side effects of the regimen were recorded in 14.3% of patients. Conclusion: The EBMT regimen is an effective treatment method for eradicating H. pylori with a high success rate, and the incidence of side effects is relatively low.
Article Details
Keywords
Helicobacter pylori, EBMT
References
2. Nguyễn Thị Lệ, Đỗ Thanh Hồng, Tống Nguyễn Bình, và cộng sự, (2023), "Hiệu quả tiệt trừ Helicobacter pylori của phác đò 4 thuóc có bismuth 10 ngày ở bệnh nhân viêm dạ dày tại Bệnh viện Trường đại học Tây nguyên", Tạp chí Khoa học Tây Nguyên, (6), tr. 111-118.
3. Thái Thị Hồng Nhung, Huỳnh Hiếu Tâm, (2020), "Nghiên cứu đặc điểm lâm sàng, hình ảnh nội soi và hiệu quả điều trị của phác đồ 4 thuốc có Bismuth trên bệnh nhân viêm loét dạ dày tá tràng do nhiễm Helicobacter pylori tại Bệnh viện Trường Đại học Y Dược Cần Thơ", Tạp chí Y Dược học - Trường Đại học Y Dược Huế, 10(3), tr, 7-12.
4. Graham, D. Y., (2014), "History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer", World J Gastroenterol, 20(18), pp. 5191-5204.
5. Malfertheiner, P., Megraud, F., et al., (2022), "Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report", Gut, 9(71), pp. 1724-1762.
6. Nguyen, L. T., Nguyen, V. B., Tran, T. V., et al., (2022), "Efficacy of Helicobacter pylori Eradication Based on Rabeprazole–Bismuth–Tetracycline–Tinidazole Regimen in Vietnamese Patients with Duodenal Ulcers", Gastroenterology Insights, 13(4), pp. 365-376.
7. Palsson, O. S., Whitehead, W. E., van Tilburg, M. A., et al., (2016), "Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians", Gastroenterology, 6(150), pp. 1481-1491
8. Wang, C., Yin, Y., Wang, L., et al., (2023), "Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis", Postgrad Med J, 99(1169), pp. 166-175.